Monday, December 1, 2025
Tag:

Cancer

JPMorgan’s Dimon: AI Cost Savings Now Aligning with Investment Outlays

Unlocking AI Innovation: JPMorgan's Game-Changing Investment Jamie Dimon, CEO of JPMorgan Chase & Co., recently revealed that the bank allocates a staggering $2 billion annually...

AI Tool Effectively Differentiates Between Glioblastoma and Primary Central Nervous System Lymphoma

Researchers from Harvard Medical School have created an AI tool named PICTURE (Pathology Image Characterization Tool with Uncertainty-aware Rapid Evaluations) that distinguishes between glioblastoma...

An Open-Source Software Pipeline for Extracting Medical Information in Oncology Using Large Language Models

The information extraction (IE) protocol encompasses four stages: problem definition and data preparation, data preprocessing, LLM-based IE, and output evaluation. Designed for clinical researchers...

How AI is Empowering My Doctors in the Fight Against Cancer

At 60, I faced concerning health issues like weight loss, fatigue, and abdominal discomfort, leading me to demand exhaustive testing from my doctors. Despite...

AI Cancer Tools: Are They Undermining Doctors’ Skills?

AI technology in healthcare promises to enhance cancer diagnosis, yet recent findings reveal potential risks. A study published in The Lancet Gastroenterology & Hepatology...

Estonian MedTech Startup Better Medicine Secures €1 Million to Enhance AI Model for Kidney Cancer Diagnosis

Tartu-based startup Better Medicine has successfully raised €1 million in a pre-Seed funding round to enhance its AI-powered diagnostic tools for radiology. Led by...

OpenAI’s ChatGPT-5 Can Identify Cancer Through Prompts, Supported by Insights from 250 Medical Experts | Inshorts

OpenAI's ChatGPT-5 is reportedly capable of identifying cancer through user prompts, marking a significant advancement in AI health technology. This model's health evaluation processes...

Integrating Large Language Models in Cancer Decision-Making: A Comprehensive Systematic Review and Meta-Analysis

In our systematic review, we analyzed 56 studies focusing on AI-based chatbots and their role in clinical decision support for cancer patients. Following rigorous...